CVS Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$54.58 |
| 52 Week High | US$80.80 |
| 52 Week Low | US$54.15 |
| Beta | 0.54 |
| 11 Month Change | -15.71% |
| 3 Month Change | -2.54% |
| 1 Year Change | -22.14% |
| 33 Year Change | -37.48% |
| 5 Year Change | n/a |
| Change since IPO | -20.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | PE Healthcare | PE Market | |
|---|---|---|---|
| 7D | -2.5% | 0% | 0% |
| 1Y | -22.1% | 0% | 0% |
Return vs Industry: CVS underperformed the PE Healthcare industry which returned -13.6% over the past year.
Return vs Market: CVS underperformed the PE Market which returned 12.8% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in PE Market | 0% |
| 10% least volatile stocks in PE Market | 0% |
Stable Share Price: CVS's share price has been volatile over the past 3 months compared to the PE market.
Volatility Over Time: CVS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of PE stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | US$66.93b |
| Earnings (TTM) | US$5.02b |
| Revenue (TTM) | US$367.25b |
13.3x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVS perform over the long term?
See historical performance and comparison